KREMEN2 and non-small cell lung carcinoma: To investigate the biological functions of Kremen2 in NSCLC, we utilized the CRISPR/Cas9 approach to generate Kremen2 knockout A549 cells (A549-Krm2KO), in which a thymidine residue was inserted leading to a frameshift mutation (Fig. S1A).